drugset
drugset / Trial / NCT00464542

Asymptomatic Bacterial Vaginosis and Herpes Simplex Virus Type 2 (BV/HSV-2) Shedding Study

NCT00464542 ↗

Phase 4 Completed 12 enrolled University of Pittsburgh
NaSingle-groupOpen-labelTreatment

Summary

This investigation assessed the effects of asymptomatic BV on daily genital tract shedding of HSV-2 by determining shedding frequency before and after treatment of asymptomatic BV.

Timeline

Start
2007-12
Primary completion
2010-03
Completion
2010-03

Drugs

EvaluationDrugModalityDoseRoute
Subject Metronidazole Small molecule 500 mg Oral

Indications

bacterial vaginosis